The Saudi Medicines Authority accompanies the Saudi Deputy Minister of Industry on a visit to a number of Egyptian pharmaceutical factories

Dr. Tamer Al-Husseini, Vice President of the Egyptian Pharmaceutical Authority, participated in a field visit by a Saudi delegation headed by Engineer Khalil bin Ibrahim bin Salama, Deputy Minister of Industry of the Kingdom of Saudi Arabia, to a number of Egyptian factories. The pharmaceutical system in the two brotherly countries.
At the beginning of the meeting, Dr. Al-Husseini welcomed the Saudi delegation, praising the depth of the fraternal relations between Egypt and Saudi Arabia and the continuous development they are witnessing in the industrial and pharmaceutical sectors, stressing that the pharmaceutical industry in Egypt is considered one of the fastest growing in the region, and that cooperation with the Kingdom represents a strategic opportunity to achieve industrial integration and enhance pharmaceutical security. Arabic.
The Egyptian Drug Authority seeks, through field visits to local factories, to enhance the industrial investment environment in Egypt, by providing technical facilities and guidance to foreign and local companies, with a focus on localizing modern technology and promoting innovation in the pharmaceutical industry sector.
The Vice Chairman of the Authority explained that the Authority is working to build strategic partnerships with various regional and international parties, ensuring the transfer of expertise and the exchange of knowledge, and enhancing Egypt’s ability to become a center. A regionally advanced pharmaceutical industry that contributes to achieving Arab pharmaceutical security and serves the interests of the Egyptian and Saudi peoples.
During the visit, the delegation was briefed on the production and technical capabilities of the factories, and listened to a detailed presentation on manufacturing systems and quality controls, expressing its appreciation for the advanced level that the pharmaceutical industry has reached in Egypt, praising the vital role played by the pharmaceutical authority in developing the sector and enhancing its competitiveness. The Saudi delegation expressed great admiration for the level of technical and productive development of Egyptian factories, praising the great efforts made by the Egyptian Medicines Authority in regulating the sector and enhancing its regional competitiveness, stressing that cooperation with Egypt constitutes an ideal model for industrial and investment partnership between the two brotherly countries, and that their visit was an opportunity to learn about the best practices in manufacturing and quality controls, which are a standard to be emulated in the region.
The Saudi delegation included Eng. Abdul Rahman bin Sulaiman Al-Dhukair, CEO of the Saudi Export Development Authority, Abdulaziz bin Muhammad Al-Mahous, Executive Vice President of the Market Access and International Offices Sector, Engineer Al-Badr bin Adel Fouda, Undersecretary for Industrial Empowerment, Dr. Ahmed bin Sami Al-Zawawi, Assistant Undersecretary for Industrial Competitiveness and Advanced Manufacturing, Ghaith Al-Balawi, Director General of Investor Relations, Counselor Nizar bin Youssef Al-Hariri, Advisor to the Minister in the Office of Vaccines and Biotechnology Industry, and Mohammed bin Abdullah Al-Junaini, Director-General. General Administration for the Development of Local and International Demand.
Participating in the visit from the Medicine Authority were Dr. Osama Hatem, Assistant to the Chairman of the Authority for Policies and International Cooperation and Supervisor of the Central Administration for Pharmaceutical Policies and Market Support, Dr. Amira Mahjoub, Head of the Central Administration for Inspection of Pharmaceutical Institutions, and a number of representatives of the General Administration for Public Relations and International Cooperation and the Investment Support Department.
This visit confirms the Egyptian Medicine Authority’s commitment to supporting and strengthening industrial and investment cooperation with the Kingdom of Saudi Arabia, and also embodies the active role The Authority is committed to developing the pharmaceutical sector and localizing modern technology within Egypt, thus strengthening its position as a leading regional center in the pharmaceutical industries.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related




